Perspectives

Perspectives

Commentary and highlights from contributors and readers

Draining the Email Swamp

On a typical weekday, I receive 200 emails and send 40. Unless you, dear reader, are the taciturn Seattle hematologist who hasn’t responded to...

Recommendations from My Bookshelf: A Bloody Mess

Imagine that you’re young, brilliant, charismatic, and you have a compelling vision for a bold new idea that could revolutionize health care: scores of...

How would you treat a patient with autoimmune hepatitis, grade 4 cirrhosis, and declining...

Here’s how readers responded to a You Make the Call question about a 22-year-old patient presenting with epistaxis, a platelet count of zero, abnormal...

My Twitter Journey

My journey to Twitter was not my idea. A few years ago, the chairman of the Cleveland Clinic Taussig Cancer Institute, Brian Bolwell, MD...

Notes From the Field

Readers responded to two of our recent articles that offered a candid look into the daily lives of physician-researchers and advice for thriving as...

Next Steps After TKIs for Patient With Chronic-Phase CML?

Here’s how readers responded to a You Make the Call question about the next steps after TKIs for patient with chronic-phase chronic myeloid leukemia. Disclaimer:...
Alice Ma, MD

Summertime Blues

At the time of writing this column, the calendar has just turned to August and another July has come and gone. There’s plenty of...

Caring About Standards of Care

I’ve been thinking a lot about standards of care recently. A “medical standard of care” is actually a legal term, typically defined as the level...

Advice for the Graduating Hematologist

When I was asked to collect some thoughts to share with hematology/oncology trainees upon completion of their fellowship, I thought back on my experiences...

A Slow Burn

In our July 2018 issue, ASH Clinical News Associate Editor Keith Stewart, MBChB, MBA, walked us through his valiant efforts to step away from...
Advertisement

Current Issue

January 2019 Annual Meeting Edition

This issue features highlights from the 2018 ASH Annual Meeting, including big data initiatives to improve prognosis in myelodysplastic syndromes, and more.